US Stocks
/
Replimune Group, Inc. Share Price

Replimune Group, Inc. Share Price

NASDAQ: REPL | Small Cap
$13.03
-$0.18 (-1.33%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Replimune Group, Inc. Stock Performance

Open
$13.15
Prev. Close
$13.21
Circuit Range
N/A
Day Range
$12.86 - $13.44
Year Range
$1.50 - $16.30
Volume
1,54,288
Average Traded
$13.09

Replimune Group, Inc. Share Price Today

As of 9 October 2026, Replimune Group, Inc.'s share price is $13.03. The stock opened at $13.15, compared to its previous close of $13.21. During today's trading session, Replimune Group, Inc.'s share price traded between $12.86 and $13.44, with an average price of $13.15. Over the past 52 weeks, the stock has recorded a high of $16.30 and a low of $1.50. In terms of performance, Replimune Group, Inc.'s share price has risen by 409.98% over the last six months and is up 34.05% on a year-on-year basis.

Replimune Group, Inc. Share Price Chart

$12.86$13.44
L
Show Current Price
H

Replimune Group, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.05B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.15
Revenue (TTM)
$0.00
Return On Equity (TTM)
-281.14%
Profit Margin
N/A
Debt to Equity
1.03
Quarterly Earnings Growth YoY
16.04%

Replimune Group, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$83.10-$70.93-$73.22-$69.77
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A14.65%-3.23%4.71%

Replimune Group, Inc. Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$174.28-$215.79-$247.30-$313.94
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-23.82%-14.60%-26.95%

About Replimune Group, Inc.

Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. Its proprietary oncolytic immunotherapy product candidates are designed and intended to maximally activate the immune system against cancer. Oncolytic immunotherapy is an emerging drug class. The proprietary RPx platform is based on a novel, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added that are intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. It operates in single segment of developing oncolytic immunotherapies for the treatment of cancer.

Replimune Group, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$13.10
$13.02
-1.81%
Sep 2026
$15.37
$13.26
-15.00%
Aug 2026
$11.27
$15.60
+39.22%
Jul 2026
$11.45
$11.21
+1.31%
Jun 2026
$8.95
$11.06
+27.13%
May 2026
$2.52
$8.70
+240.51%
Apr 2026
$7.78
$2.56
-66.56%
Mar 2026
$7.55
$7.64
-0.20%
Feb 2026
$6.93
$7.66
+9.05%
Jan 2026
$9.71
$7.02
-27.70%
Dec 2025
$10.00
$9.71
-3.00%
Nov 2025
$9.40
$10.01
+2.98%

REPL Share Price FAQs

What is Replimune Group, Inc. share price today?

chevron-up
Replimune Group, Inc. share price today is $13.03 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Replimune Group, Inc. stock?

chevron-up
The 52 week high of Replimune Group, Inc. stock is $16.30, while the 52 week low is $1.50 as of 9 Oct '26.

What is REPL's market capitalisation today?

chevron-up
REPL market capitalisation is $1.05B as of October 9, 2026, at 6:09 pm IST.

What is REPL's net income for the last quarter?

chevron-up
REPL's net income for the last quarter is -69.77B USD.

What is the 5 year returns of REPL?

chevron-up
The 5 year returns of REPL is -55.85% as on 9 Oct '26.

What is the high & low stock price of REPL today?

chevron-up
REPL stock price hit a high of $13.44 and low of $12.86 as of 9 Oct '26.

Can I buy REPL shares in India?

chevron-up
Yes. You can buy REPL in India by opening an international trading account.